168
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

The efficacy of mizoribine for the treatment of rheumatoid arthritis and its correlation with renal function

, , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 892-896 | Received 26 Jul 2013, Accepted 15 Jan 2014, Published online: 04 Mar 2014

References

  • Nishimura K, Nishino J, Kouchi A, Nakamura N, Nakajima S, Yokoe I, et al. Efficacy and safety of single-dose mizoribine for patients with rheumatoid arthritis: results at 6 months after switching from a multiple-dose regimen without a change in total daily dose. Mod Rheumatol. 2011;21(2):158–63.
  • Ichinose K, Ida H, Kawakami A, Tsukada T, Ueki Y, Eguchi K, et al. Efficacy and safety of mizoribine by one single dose administration for patients with rheumatoid arthritis. Inter Med. 2010;49(20):2211–8.
  • Kohriyama K, Hiramatsu Y, Aoyama T. Efficacy of combination pulse therapy with methotrexate and mizoribine for patients with rheumatoid arthritis showing escape phenomenon to low-dose methotrexate therapy (in Japanese). Clin Rheumatol. 2003;15(3):227–34.
  • Murai T, Arai K, Fujisawa J, Ito S. Efficacy and safety of combination pulse therapy with methotrexate and mizoribine in rheumatoid arthritis patients (in Japanese). Jpn J Joint Dis. 2009;28(1):21–7.
  • Kasama T, Wakabayashi K, Odai T, Isozaki T, Matsunaga M, Yajima N, et al. Effects of low-dose mizoribine pulse therapy in combination with methotrexate in rheumatoid arthritis patients with an insufficient response to methotrexate. Mod Rheumatol. 2009;19(4):395–400.
  • Suzuki D, Kimoto O, Sawada J, Shimoyama K, Kawashima M, Mukai T, et al. The efficacy and safety of combination therapy with mizoribine and methotrexate for rheumatoid arthritis resistant methotrexate (in Japanese). Jpn J Clin Immunol. 2011;34(3):149–53.
  • Ito S. Treatment for rheumatoid arthritis in elderly patients to be provided by orthopedic surgeons (in Japanese). Jpn J Joint Dis. 2008;27(1):39–50.
  • Nakamura S, Tokugawa S, Nakase M, Sakinaga Y, Taniguchi D. Clinical study of mizoribine for rheumatoid arthritis in our hospital (in Japanese). Clin Rheumatol. 2011;23(3):168–72.
  • Nishimura K, Itoh K, Kuga Y, Uchida S, Nishino J, Nakamura N, et al. Prevention of joint destruction in rheumatoid arthritis patients receiving combination methotrexate and mizoribine therapy: a two year, multicenter open-comparison study to methotrexate monotherapy. Prog Med. 2006;26(9):2163–72.
  • Moriguchi M, Terai C, Koseki Y, Uesato M, Kamatani N. Renal function estimated from serum creatinine is overestimated in patients with rheumatoid arthritis because of their muscle atrophy. Mod Rheumatol. 2000;10(4):230–4.
  • Sato H, Kuroda T, Tanabe N, Ajiro J, Wada S, Murakami S, et al. Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis. Scand J Rheumatol. 2010;39(1):33–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.